Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physicians’ Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 3.5 Contact Hours.
This activity is supported by educational grants from AstraZeneca, Biocept, Inc., Foundation Medicine, Inc., Genomic Health, Guardant Health, and Novartis Pharmaceuticals Corporation.
117 West 46th Street
New York, NY
Successful patient selection and implementation of tumor interrogation methods, including emerging technologies such as liquid biopsies, are essential to providing timely, accurate characterization of different types of solid tumors, which can have a tremendous influence on treatment selection, and ultimately, patient outcomes. Precision Medicine Through Plasma: Using Liquid Biopsies in Contemporary Oncology Care is being launched to address the rapidly evolving science and associated therapeutic developments resulting from the emergence of novel testing strategies such as liquid biopsies. In this half-day symposium, key experts in lung, breast, and gastrointestinal malignancies will provide an overview of the latest clinical data on liquid biopsies, followed by detailed case discussions among a multidisciplinary faculty. Ample question-and-answer time will also be provided for attendees to interact directly with the expert faculty.
Key topics to be addressed include:
This educational activity is intended for medical oncologists, pathologists, and fellows who treat patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other healthcare professionals interested in the treatment of cancer are also invited to participate. 2018-12-02 00:00:00
ONS: PER Forum™: Nursing Opportunities to Improve Outcomes With the Advent of PARP Inhibitors in the Care of Women’s Cancers
May 17, 2018
ONS: Working Group for Changing Standards in EGFR-Mutated Lung Cancers: Real-World Applications of the Evidence for Nurses
May 17, 2018
Medical Crossfire®: Clinical Updates on PARP Inhibition and its Evolving Use in the Treatment of Cancers
May 30, 2018
May 31, 2018
May 31, 2018